Altimmune
(NASDAQ) ALT
Altimmune Financials at a Glance
Market Cap
$558.14M
Revenue (TTM)
$36.00K
Net Income (TTM)
-$91.08M
EPS (TTM)
-$0.94
P/E Ratio
-3.06
Dividend
$0.00
Beta (Volatility)
1.26 (Average)
Dividend
$0.00
Beta (Volatility)
1.26 (Average)
Price
$2.82
Volume
172,511
Open
$2.85
Price
$2.82
Volume
172,511
Open
$2.85
Previous Close
$2.82
Daily Range
$2.75 - $2.89
52-Week Range
$2.56 - $6.44
Estimated Earnings Date
Aug 11, 2026
Dividend
$0.00
Beta (Volatility)
1.26 (Average)
Price
$2.82
Volume
172,511
Open
$2.85
Previous Close
$2.82
Daily Range
$2.75 - $2.89
52-Week Range
$2.56 - $6.44
Estimated Earnings Date
Aug 11, 2026
ALT News
ALT: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Altimmune
Industry
Biotechnology
Sector
Health CareEmployees
57
CEO
Jerome B. Durso
Website
www.altimmune.comHeadquarters
Gaithersburg, MD 20878, US
ALT Financials
Key Financial Metrics (TTM)
Gross Margin
-41519.44%
Operating Margin
-269216.67%
Net Income Margin
-253002.78%
Return on Equity
-42.57%
Return on Capital
-36.26%
Return on Assets
-27.14%
Earnings Yield
-32.68%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$558.14M
Shares Outstanding
194.47M
Volume
172.51K
Avg. Volume
3.84M
Financials (TTM)
Gross Profit
-$14.95M
Operating Income
-$96.92M
EBITDA
-$88.27M
Operating Cash Flow
-$71.64M
Capital Expenditure
-$32.00K
Free Cash Flow
-$71.67M
Cash & ST Invst.
$331.54M
Total Debt
$35.85M
Altimmune Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
-$23.00K
-560.0%
Gross Margin
0.00%
N/A
Market Cap
$558.14M
N/A
Market Cap/Employee
$9.46M
N/A
Employees
59
N/A
Net Income
-$22.56M
-15.3%
EBITDA
-$21.47M
-6.2%
Quarterly Fundamentals
Total Cash
$331.54M
+121.3%
Total Debt
$35.85M
+2158.8%
Accounts Receivable
$1.67M
-32.4%
Inventory
$0.00
N/A
Long Term Debt
$35.58M
+2551.4%
Short Term Debt
$265.00K
+8.2%
Return on Assets
-27.14%
N/A
Return on Invested Capital
-29.88%
N/A
Free Cash Flow
-$20.96M
-24.5%
Operating Cash Flow
-$20.94M
-24.4%